Sarepta Therapeutics, Inc.SRPTNASDAQ

Revenue (LTM)

$2.2B

+15.6% YoY

Net Income (LTM)

$-713M

-403.3% YoY

Free Cash Flow

$-307M

Revenue CAGR (5Y)

+32.4%

Marginsdeclining

FCF($0.3B)

Now unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	702	933↑32.9%	1,243↑33.3%	1,902↑53.0%	2,198↑15.6%
Gross Profit	605	793↑31.1%	1,093↑37.8%	1,583↑44.8%	1,317↓16.8%
Operating Income	-460	-536↓16.6%	-268↑50.1%	218↑181.4%	-658↓401.6%
Net Income	-419	-703↓68.0%	-536↑23.8%	235↑143.9%	-713↓403.3%
EBITDA	-317	-595↓87.4%	-454↑23.7%	317↑169.8%	-648↓304.5%
EPS Diluted	-5.15	-8.03↓55.9%	-5.80↑27.8%	2.34↑140.3%	-7.13↓404.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	2,116	967↓54.3%	428↓55.7%	1,103↑157.5%	801↓27.4%
Total Current Assets	2,604	2,558↓1.8%	2,579↑0.8%	3,073↑19.2%	2,538↓17.4%
Total Assets	3,148	3,128↓0.6%	3,265↑4.4%	3,963↑21.4%	3,350↓15.5%
Total Current Liabilities	453	620↑36.9%	654↑5.5%	732↑11.9%	1,095↑49.7%
Total Liabilities	2,220	2,743↑23.6%	2,405↓12.3%	2,435↑1.3%	2,209↓9.3%
Total Equity	928	385↓58.5%	859↑123.2%	1,528↑77.8%	1,141↓25.3%
Total Debt	1,153	1,617↑40.2%	1,397↓13.6%	1,343↓3.8%	1,040↓22.6%
Net Debt	-962	651↑167.6%	968↑48.8%	240↓75.2%	238↓0.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-443	-325↑26.6%	-501↓54.0%	-206↑58.9%	-205↑0.1%
Capital Expenditure	-38	-32↑16.2%	-87↓170.8%	-147↓68.2%	-102↑30.6%
Free Cash Flow	-482	-358↑25.8%	-588↓64.5%	-353↑40.0%	-307↑12.8%
Stock-Based Comp	114	233↑104.5%	183↓21.7%	184↑1.0%	123↓33.0%
Net Change in Cash	614	-1,140↓285.7%	-542↑52.5%	675↑224.5%	-304↓145.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance